Nanjing Leads Biolabs Co.,Ltd

Fuzhou, Fujian

OncologymRNAFiled/Approved

Compare Sign in to watch

What changed

Study registered, no phase assigned: Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System

3w agoTrial registeredJun 24, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

31 pre-ticker oncology companies at Filed/Approved

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
K99 · $120k · non-dilutive
Mar 1, 2026
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, YU · NIA · award ends Feb 29, 2028 · Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory
NIH RePORTER · NIH RePORTER 11283615 (opens the source filing in a new tab)
Grant
R01 · $713k · non-dilutive
Feb 1, 2026
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · NIA · award ends Dec 31, 2030 · A prospective study of viral infections and subsequent risk of Alzheimer’s disease
NIH RePORTER · NIH RePORTER 11229846 (opens the source filing in a new tab)
Grant
R01 · $725k · non-dilutive
Jan 1, 2026
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · NIA · award ends Nov 30, 2030 · Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women
NIH RePORTER · NIH RePORTER 11304392 (opens the source filing in a new tab)
Grant
R01 · $2.2M · non-dilutive
Sep 12, 2025
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AHN, JIYOUNG · NHLBI · award ends Jun 30, 2029 · Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome
NIH RePORTER · NIH RePORTER 11103656 (opens the source filing in a new tab)
Grant
R01 · $2.4M · non-dilutive
Sep 10, 2025
CHILDREN'S HOSP OF PHILADELPHIA · PI CHEN, YU-HAN · NICHD · award ends Aug 31, 2028 · Neural markers of late language emergence in preschool children born very and extremely preterm
NIH RePORTER · NIH RePORTER 11208471 (opens the source filing in a new tab)
Trial
PHASE1/PHASE2 registered
Sep 5, 2025
Advanced Melanoma · RECRUITING · sponsor: Nanjing Leads Biolabs Co.,Ltd · A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
ClinicalTrials.gov · NCT07099430 (opens the source filing in a new tab)
Grant
U01 · $703k · non-dilutive
Sep 1, 2025
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · NCI · award ends Aug 31, 2030 · A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study
NIH RePORTER · NIH RePORTER 11044553 (opens the source filing in a new tab)
Grant
R01 · $1.2M · non-dilutive
Sep 1, 2025
SLOAN-KETTERING INST CAN RESEARCH · PI CHEN, YU · NCI · award ends Aug 31, 2027 · Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
NIH RePORTER · NIH RePORTER 11144600 (opens the source filing in a new tab)
Grant
K23 · $164k · non-dilutive
Aug 7, 2025
KESSLER FOUNDATION, INC. · PI CHEN, YU-LUN · NICHD · award ends Jul 31, 2030 · Physical Activity in Transition-Age Youth on the Autism Spectrum
NIH RePORTER · NIH RePORTER 11114409 (opens the source filing in a new tab)
Grant
R01 · $2.9M · non-dilutive
Aug 1, 2025
UNIVERSITY OF SOUTH FLORIDA · PI CHEN, YU · NIAID · award ends Jul 31, 2029 · Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets
NIH RePORTER · NIH RePORTER 11234622 (opens the source filing in a new tab)
Grant
R21 · $218k · non-dilutive
May 1, 2025
UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, YU-CHIH · NCI · award ends Apr 30, 2027 · Halting Breast Cancer Metastasis by Blocking Cancer-MSC Engulfment
NIH RePORTER · NIH RePORTER 11321699 (opens the source filing in a new tab)
Grant
R00 · $249k · non-dilutive
Jul 1, 2024
TEMPLE UNIV OF THE COMMONWEALTH · PI CHEN, YU-CHIEH DAVID · NEI · award ends Jun 30, 2029 · Molecular control of stochastic color vision circuit assembly
NIH RePORTER · NIH RePORTER 11459111 (opens the source filing in a new tab)
Grant
OT2 · $610k · non-dilutive
May 1, 2024
BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · NCI · award ends Apr 30, 2027 · MATCHMAKERS: Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
NIH RePORTER · NIH RePORTER 11514454 (opens the source filing in a new tab)
Trial
PHASE4 registered
Apr 12, 2023
Acute Coronary Syndrome, Helicobacter Pylori Infection · RECRUITING · sponsor: Qilu Hospital of Shandong University · The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
ClinicalTrials.gov · NCT04728516 (opens the source filing in a new tab)
Trial
NA registered
Aug 17, 2021
Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy · ACTIVE_NOT_RECRUITING · sponsor: Shanghai Changzheng Hospital · Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
ClinicalTrials.gov · NCT04968028 (opens the source filing in a new tab)
Trial
NA registered
Apr 20, 2021
Osteoporosis, Osteoporotic Vertebral Compression Fractures · RECRUITING · sponsor: Juin-Hong Cherng · Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System
ClinicalTrials.gov · NCT07665424 (opens the source filing in a new tab)
Trial
Study registered
May 16, 2016
Cancer, Cardiovascular Diseases · RECRUITING · sponsor: NYU Langone Health · Food and Microbiome Longitudinal Investigation (FAMiLI)
ClinicalTrials.gov · NCT03293758 (opens the source filing in a new tab)
Grant
P50 · $2.1M · non-dilutive
Sep 14, 2001
SLOAN-KETTERING INST CAN RESEARCH · PI CHEN, YU · NCI · award ends Aug 31, 2027 · SPORE in Prostate Cancer
NIH RePORTER · NIH RePORTER 11173716 (opens the source filing in a new tab)
Grant
P50 · $213k · non-dilutive
Sep 14, 2001
SLOAN-KETTERING INST CAN RESEARCH · PI CHEN, YU · NCI · award ends Aug 31, 2027 · Core D: Preclinical Models Core
NIH RePORTER · NIH RePORTER 11173744 (opens the source filing in a new tab)
Grant
P30 · $36k · non-dilutive
Dec 1, 1996
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AHN, JIYOUNG · NCI · award ends Feb 28, 2029 · Epidemiology & Cancer Control (ECC) Research Program
NIH RePORTER · NIH RePORTER 11317121 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 82%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75principal investigator CHEN, YU-LUN is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75principal investigator CHEN, YU is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System
3w agoTrial recruitingSource (opens the source filing in a new tab)
NIH R00 · $0.2M · Molecular control of stochastic color vision circuit assembly
5w agoGrant renewalSource (opens the source filing in a new tab)
Phase II trial registered: A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
2mo agoTrial registeredSource (opens the source filing in a new tab)
NIH P30 · $0.0M · Epidemiology & Cancer Control (ECC) Research Program
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R21 · $0.2M · Halting Breast Cancer Metastasis by Blocking Cancer-MSC Engulfment
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH OT2 · $0.6M · MATCHMAKERS: Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH K99 · $0.1M · Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory
4mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Food and Microbiome Longitudinal Investigation (FAMiLI)
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Food and Microbiome Longitudinal Investigation (FAMiLI)
4mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women
5mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.7M · A prospective study of viral infections and subsequent risk of Alzheimer’s disease
5mo agoNew grantSource (opens the source filing in a new tab)
Filed/Approved trial registered: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
10mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
10mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH R01 · $2.2M · Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome
10mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $2.4M · Neural markers of late language emergence in preschool children born very and extremely preterm
10mo agoNew grantSource (opens the source filing in a new tab)
NIH P50 · $2.1M · SPORE in Prostate Cancer
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P50 · $0.2M · Core D: Preclinical Models Core
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH U01 · $0.7M · A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study
10mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $1.2M · Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH K23 · $0.2M · Physical Activity in Transition-Age Youth on the Autism Spectrum
11mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $2.9M · Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets
12mo agoNew grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

K99 · $120k · non-dilutive

R01 · $713k · non-dilutive

R01 · $725k · non-dilutive

R01 · $2.2M · non-dilutive

R01 · $2.4M · non-dilutive

PHASE1/PHASE2 registered

U01 · $703k · non-dilutive

R01 · $1.2M · non-dilutive

K23 · $164k · non-dilutive

R01 · $2.9M · non-dilutive

R21 · $218k · non-dilutive

R00 · $249k · non-dilutive

OT2 · $610k · non-dilutive

PHASE4 registered

NA registered

NA registered

Study registered

P50 · $2.1M · non-dilutive

P50 · $213k · non-dilutive

P30 · $36k · non-dilutive